Methods of treating cancer by targeting drivers
AssigneeDelta Next-Gene, LLC
InventorsErlinda M. Gordon, Fredrick L. Hall
Life of this patent
Estimating the term…
Loading patent…
AssigneeDelta Next-Gene, LLC
InventorsErlinda M. Gordon, Fredrick L. Hall
Estimating the term…
The present disclosure provides methods of using combination therapies to treat cancer. These methods are based on inhibiting cyclin proteins along with proteins along the Cyclin Axis. Thus, a method of the disclosure may generally be practiced by administering to an individual having cancer a cytocidal inhibitor of cyclin, along with a therapeutic agent that targets other molecules involved in pathways that promote cyclin activity. These therapeutic agents may target biomarkers on the surface of a cancer cell and that promote cyclin activity as well as intracellular proteins involved in pathways that affect, or are affected by, cyclin activity.
A method of treating a cancer in an individual, wherein the cancer cells express at least one biomarker that is part of a biochemical pathway that promotes cyclin protein activity, the method comprising administering to the individual:
Dependencies are inferred from the claim text.